CA1073461A - Heterocyclic compounds - Google Patents

Heterocyclic compounds

Info

Publication number
CA1073461A
CA1073461A CA275,531A CA275531A CA1073461A CA 1073461 A CA1073461 A CA 1073461A CA 275531 A CA275531 A CA 275531A CA 1073461 A CA1073461 A CA 1073461A
Authority
CA
Canada
Prior art keywords
pyridin
compound
isothiazolo
ethyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA275,531A
Other languages
English (en)
French (fr)
Inventor
Keith H. Baggaley
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Application granted granted Critical
Publication of CA1073461A publication Critical patent/CA1073461A/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
CA275,531A 1976-04-28 1977-04-04 Heterocyclic compounds Expired CA1073461A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB17165/76A GB1560726A (en) 1976-04-28 1976-04-28 Isothiazolo-pyridines

Publications (1)

Publication Number Publication Date
CA1073461A true CA1073461A (en) 1980-03-11

Family

ID=10090431

Family Applications (1)

Application Number Title Priority Date Filing Date
CA275,531A Expired CA1073461A (en) 1976-04-28 1977-04-04 Heterocyclic compounds

Country Status (18)

Country Link
JP (1) JPS52131597A (en:Method)
AT (1) AT359063B (en:Method)
AU (1) AU2451277A (en:Method)
BE (1) BE853779A (en:Method)
CA (1) CA1073461A (en:Method)
DE (1) DE2718707A1 (en:Method)
DK (1) DK185577A (en:Method)
ES (1) ES457993A1 (en:Method)
FI (1) FI771236A7 (en:Method)
FR (1) FR2349591A1 (en:Method)
GB (1) GB1560726A (en:Method)
HU (1) HU174416B (en:Method)
IE (1) IE44873B1 (en:Method)
IL (1) IL51812A0 (en:Method)
NL (1) NL7704542A (en:Method)
NZ (1) NZ183755A (en:Method)
SE (1) SE7704800L (en:Method)
ZA (1) ZA771963B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130005705A1 (en) * 2011-06-30 2013-01-03 Abbott Laboratories Novel inhibitor compounds of phosphodiesterase type 10a

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU84091A1 (fr) * 1982-04-16 1984-03-02 Oreal Derives n-carbamoyl d'isothiazolo-(5,4b)pyridine one-3,leur procede de preparation et leurs utilisations comme agents bactericides et fongicides
LU84491A1 (fr) * 1982-11-26 1984-06-13 Oreal Composition anti-acneique contenant en tant que compose actif un derive d'isothiazolo-(5,4b) pyridine one-3
FR2555450B1 (fr) * 1983-11-24 1988-04-01 Oreal Composition anti-acneique contenant en tant que compose actif un derive d'isothiazolo-(5,4b) pyridine one-3
US5734081A (en) * 1994-08-05 1998-03-31 Warner-Lambert Company Arylthio compounds
US5620997A (en) * 1995-05-31 1997-04-15 Warner-Lambert Company Isothiazolones
US6001863A (en) * 1996-11-26 1999-12-14 Warner-Lambert Company Isothiazolones
JP4982790B2 (ja) * 2006-09-26 2012-07-25 独立行政法人産業技術総合研究所 イソチアゾロピリジン−3−オン化合物の製造方法
JP4853911B2 (ja) * 2006-09-26 2012-01-11 独立行政法人産業技術総合研究所 イソチアゾロピリジン−3−オン化合物の製造方法
JP4853910B2 (ja) * 2006-09-26 2012-01-11 独立行政法人産業技術総合研究所 イソチアゾロピリジン−3−オン化合物の製造方法
FR2968661B1 (fr) * 2010-12-14 2016-01-01 Oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones
FR3115207B1 (fr) 2020-10-15 2022-10-07 Oreal Utilisation de composés thiopyridinones pour prévenir la formation des points noirs cutanés

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20130005705A1 (en) * 2011-06-30 2013-01-03 Abbott Laboratories Novel inhibitor compounds of phosphodiesterase type 10a
US9938269B2 (en) * 2011-06-30 2018-04-10 Abbvie Inc. Inhibitor compounds of phosphodiesterase type 10A

Also Published As

Publication number Publication date
BE853779A (fr) 1977-10-20
GB1560726A (en) 1980-02-06
ES457993A1 (es) 1978-07-16
FR2349591A1 (fr) 1977-11-25
ZA771963B (en) 1978-03-29
HU174416B (hu) 1980-01-28
IE44873B1 (en) 1982-04-21
IE44873L (en) 1977-10-28
IL51812A0 (en) 1977-06-30
FR2349591B1 (en:Method) 1980-02-01
FI771236A7 (en:Method) 1977-10-29
NL7704542A (nl) 1977-11-01
NZ183755A (en) 1979-03-28
AU2451277A (en) 1978-10-26
DK185577A (da) 1977-10-29
AT359063B (de) 1980-10-27
ATA291977A (de) 1980-03-15
JPS52131597A (en) 1977-11-04
SE7704800L (sv) 1977-10-29
DE2718707A1 (de) 1977-11-10

Similar Documents

Publication Publication Date Title
SU1375127A3 (ru) Способ получени производных 1,2-диаминоциклобутен-3,4-диона или их хлоргидратов
CA1073461A (en) Heterocyclic compounds
US4212979A (en) 2-Substituted benzisothiazolones
CA2188918A1 (en) Novel quinolone 5-(n-heterosubstituted amino) antimicrobials
AU703634B2 (en) Novel crystalline forms of anhydrous 7-{(1alpha,5alpha, 6alpha)-6-amino-3-azabicyclo(3.1.0)hex-3-y1}-6-fluoro-1- (2,4-difluorophenyl)-1,4-dihydro-4-oxo-1,8-naphthyridine-3- carboxylic acid, methanesulfonic acid salt.
DK149024B (da) Analogifremgangsmaade til fremstilling af krystallinske vandoploeselige salte af n-(2-pyridyl)-2-methyl-4-hydroxy-2h-1,2-benzothiazin-3-carboxamid-1,1-dioxid
US3847921A (en) Pharmacologically active 3-piperazinyl-carbonyloxy-2-pyridyl-isoindolin-1-ones
GB1593609A (en) Pyridine sulfonamides
JPH05504358A (ja) 置換尿素化合物及びそれらの製法及び使用
US3719671A (en) 10-imidoylphenothiazines
US3822269A (en) 6-aminoalkylamino-hexahydrophenanthridines useful as antiarrhythmic agents
EP0008652A1 (de) Neue Zwischenprodukte und deren Verwendung zur Herstellung von neuen Oxadiazolopyrimidinderivaten
US4187303A (en) Thiazine derivatives
EP0000254B1 (en) Antithrombotic 2-(gamma-(1-piperidinyl)propyl)1,2-benzisothiazol 3-one, its pharmaceutically acceptable acid addition salts, their preparation and their compositions
IE46375B1 (en) 3-imino-1,5,10,10a-tetrahydrothiazolo(3,4-b)isoquinoline derivatives
US4164579A (en) Hydroxythiazolidine-2-thiones
KR860000103B1 (ko) 3'-치환-5'-(2-아미노-4-피리딜)-1', 2', 4'-트리아졸류의 제조 방법
US4189480A (en) Isoquinoline derivatives
IE45293B1 (en) Esters of penicillin antibiotics
DE2753391A1 (de) Benzisothiazolone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
US4450109A (en) Thiazinobenzimidazole derivatives
CS198166B2 (en) Method of producing new 1,1-disubstituted octahydroindolo/2,3-a/quinolizines
KR800001069B1 (ko) 벤즈이소티아졸른류의 제조방법
SE441357B (sv) 4-pyridino - cyanoguanidinderivat, forfarande for framstellning av detta samt en komposition med blodtryckssenkande verkan
Martinez-Merino et al. NEW 5-SUBSTITUTED DERIVATIVES OF ETHYL 2, 3-DIHYDRO

Legal Events

Date Code Title Description
MKEX Expiry